Researchers at the Wuhan Institute of Virology, China, have said that they have discovered a new Kornavirus in bats. Chinese researchers say that this virus found in bats enters humans’ cells in the same way as the Kovid-19 virus (Sars-Cov-2). He says that this has increased the chances of its infection in humans.
Chinese researchers said in research published in Cell magazine that the virus does not enter humans as easily as Sars-Cov-2 and this virus also has some limitations.
Scientists stated that like Sars-Cov-2, the bats virus HKU5-Cov-2 contains a feature called furine cleavage site that helps it to enter the cell through the Ace2 receptor protein on the cell surfaces.
What was seen in the experiment in the lab on the bat virus?
The experiments conducted in the lab were observed that HKU5-Cov-2 test tubes are infecting human cells with high Ace2 levels in the models of human intestines and airways.
In further experiments, researchers detected monoclonal antibodies and antiviral drugs to target the virus of bats.
Kovid vaccine companies climbed up
On Friday, Bloomberg published a report stating that with the identity of the bat virus, shares of companies making Covid vaccine have run up rapidly.
Fizer’s shares closed up 1.5% on Friday, modern (MRNA.O) shares climbed 5.3% and Novawax (Nvax.o) shares were about 1% up. This bounce in shares of Covid vaccine companies has come at a time when the entire stock market is rolling down.
Will the epidemic come again?
The 2019 Kovid epidemic caused huge havoc all over the world. The world is still recovering from this that a new virus has come out. This has increased the concern of spreading epidemic once again.
On these concerns, Dr. Michael Oosterhom, infectious pathologist at Minnesota University, said that this is not going to happen at the moment. He said that compared to 2019, this time people have a lot of immunity towards Sars virus, which can reduce the risk of epidemic.